Mesoblast (MESO) Deferred Taxes (2016 - 2025)
Mesoblast's (MESO) quarterly Deferred Taxes came in at $212000.0 in Q2 2025, up 307.84% year-on-year from $51980.8 in Q2 2024, and up 307.84% quarter-over-quarter from -$102000.0 in Q2 2024.
Mesoblast (MESO) Deferred Taxes (2016 - 2025) Analysis & Trends
Mesoblast has disclosed Deferred Taxes across 10 years of filings, most recently posting $212000.0 for Q2 2025.
- Deferred Taxes for Q2 2025 came in at $212000.0, up 307.84% year-over-year; the trailing twelve-month figure through Jun 2025 was -$118000.0 (up 76.49% YoY), and the FY2025 annual result was $212000.0, up 307.84% from the prior year.
- Deferred Taxes came in at $212000.0 for Q2 2025 at Mesoblast, up from -$102000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $212000.0 in Q2 2025 to a low of -$754000.0 in Q1 2021.
- The 5-year median for Deferred Taxes is -$126000.0 (2022), against an average of -$196692.3.
- Across the five-year window, Deferred Taxes climbed 8.02% in 2023 and jumped 307.84% in 2025, its largest moves.
- Mesoblast's Deferred Taxes stood at -$142000.0 in 2021, then advanced by 11.27% to -$126000.0 in 2022, then rose by 19.05% to -$102000.0 in 2023, then changed by 0.0% to -$102000.0 in 2024, then soared by 307.84% to $212000.0 in 2025.
- The last three Deferred Taxes figures came in at $212000.0 (Q2 2025), -$102000.0 (Q2 2024), and -$102000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 212,000.00 |
| Jun 30, 2024 | -102,000.00 |
| Dec 31, 2023 | -102,000.00 |
| Jun 30, 2023 | -126,000.00 |
| Mar 31, 2023 | -172,000.00 |
| Dec 31, 2022 | -126,000.00 |
| Sep 30, 2022 | -55,000.00 |
| Jun 30, 2022 | -187,000.00 |
| Mar 31, 2022 | -187,000.00 |
| Dec 31, 2021 | -142,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Jun 30, 2021 | -754,000.00 |
| Mar 31, 2021 | -754,000.00 |
| Dec 31, 2020 | -656,000.00 |
| Sep 30, 2020 | -730,000.00 |
| Jun 30, 2020 | -6.16 Mn |
| Mar 31, 2020 | -6.16 Mn |
| Dec 31, 2019 | -4.20 Mn |
| Sep 30, 2019 | -1.93 Mn |
| Jun 30, 2019 | -5.78 Mn |